WHO ICTRP trial
Ketamine infiltration decreases opioid requirement after thyroid surgery
PACTR202210634713270 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202210634713270 |
|---|---|
| Public title | Ketamine infiltration decreases opioid requirement after thyroid surgery |
| Scientific title | Ketamine infiltration decreases opioid requirement after thyroid surgery |
| Primary sponsor | Habib Bourguiba University Hospital |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase-4 |
| Countries | Tunisia |
| Conditions | Ear, Nose and Throat;Ear, Nose and Throat |
| Interventions | Group K ;Group S |
| Registration date | Oct 10, 2022 |
| Target size | 62 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: